184 related articles for article (PubMed ID: 25532410)
21. [Study of analysis 1 390 adverse drug reactions cases of parenterally administered dengzhan xixin based on China's spontaneous response system].
Li YY; Xiang YY; Xie YM; Shen H
Zhongguo Zhong Yao Za Zhi; 2013 Sep; 38(18):2998-3002. PubMed ID: 24471319
[TBL] [Abstract][Full Text] [Related]
22. Safety of the Xuesaitong injection in China: results from a large-scale multicentre post-marketing surveillance study in a real-world setting.
He Y; Gao XM; Li L; Liu XG; Liu W; Hong XJ; Huang BH; Yang HL; Xue MH; Wu XJ; Liu JF
Curr Med Res Opin; 2020 Dec; 36(12):1947-1953. PubMed ID: 33016133
[TBL] [Abstract][Full Text] [Related]
23. [Building safety evidence body of shuxuetong injection].
Jiang JJ; Liao X; Xie YM
Zhongguo Zhong Yao Za Zhi; 2014 Sep; 39(18):3630-2. PubMed ID: 25532409
[TBL] [Abstract][Full Text] [Related]
24. [Literature review on premarketing and postmarketing evidence of xiyanping injection].
Wang ZF; Chen X; Zhang W; Xie YM
Zhongguo Zhong Yao Za Zhi; 2014 Sep; 39(18):3637-40. PubMed ID: 25532411
[TBL] [Abstract][Full Text] [Related]
25. [Research on early warning signals of adverse drug reactions to parenterally administered xiyanping based on spontaneous reporting system (SRS) data].
Wang ZF; Xiang YY; Xie YM
Zhongguo Zhong Yao Za Zhi; 2013 Sep; 38(18):3008-12. PubMed ID: 24471321
[TBL] [Abstract][Full Text] [Related]
26. [Analysis of clinical use of post-marketing hospital centralized monitoring of Xiyanping injection].
Zhao Y; Shi C; Huang P
Zhongguo Zhong Yao Za Zhi; 2016 Feb; 41(4):743-747. PubMed ID: 28871704
[TBL] [Abstract][Full Text] [Related]
27. [Research and implementation of adverse reaction automatic warning algorithm on Chinese medicine injection].
Zhuang Y; Xie BT; Xie YM; Weng SX
Zhongguo Zhong Yao Za Zhi; 2012 Sep; 37(18):2695-7. PubMed ID: 23285911
[TBL] [Abstract][Full Text] [Related]
28. [Reevaluation on adverse reaction monitoring and safety of proprietary Chinese medicines of Chongqing from 2005 to 2011].
Yang YY; Dong Z; Zhu SB; Sun HF; Yang MP
Zhongguo Zhong Yao Za Zhi; 2012 Dec; 37(23):3659-63. PubMed ID: 23477159
[TBL] [Abstract][Full Text] [Related]
29. [Influencing factor and mechanism analysis of adverse drug reaction in traditional Chinese medicine injection].
Wei X; Xie YM
Zhongguo Zhong Yao Za Zhi; 2012 Sep; 37(18):2748-51. PubMed ID: 23285926
[TBL] [Abstract][Full Text] [Related]
30. [Exploration of how to formulate guidelines on post-marketing traditional Chinese medicine surveillance].
Zhang W; Xie YM; Yu WY
Zhongguo Zhong Yao Za Zhi; 2013 Sep; 38(18):2943-8. PubMed ID: 24471309
[TBL] [Abstract][Full Text] [Related]
31. [Enlightenment of adverse reaction monitoring on safety evaluation of traditional Chinese medicines].
Song HB; Du XX; Ren JT; Yang L; Guo XX; Pang Y
Zhongguo Zhong Yao Za Zhi; 2015 Apr; 40(8):1620-3. PubMed ID: 26281610
[TBL] [Abstract][Full Text] [Related]
32. [A discussion of key issues on postmarketing reevaluation of Chinese medicine].
Xie Y; Tian F
Zhongguo Zhong Yao Za Zhi; 2010 Jun; 35(11):1494-7. PubMed ID: 20822029
[TBL] [Abstract][Full Text] [Related]
33. Adverse events to Houttuynia injection: A systematic review.
Wang L; Cui X; Cheng L; Yuan Q; Li T; Li Y; Deng S; Shang H; Bian Z
J Evid Based Med; 2010 Aug; 3(3):168-76. PubMed ID: 21349062
[TBL] [Abstract][Full Text] [Related]
34. [Systematic report on re-evaluating kudiezi injection].
Liao X; Hua GQ; Xie YM; Liu DH
Zhongguo Zhong Yao Za Zhi; 2014 Sep; 39(18):3626-9. PubMed ID: 25532408
[TBL] [Abstract][Full Text] [Related]
35. [32 546 intensive hospital monitoring cases of Shuxuetong injection].
Jiang JJ; Xie YM; Zhang Y; Yang ZX; Yi DH
Zhongguo Zhong Yao Za Zhi; 2016 Oct; 41(20):3852-3858. PubMed ID: 28929666
[TBL] [Abstract][Full Text] [Related]
36. [Discussion on establishment of quality control system for intensive hospital monitoring on traditional Chinese medicine injections].
Jiang JJ; Xie YM
Zhongguo Zhong Yao Za Zhi; 2012 Sep; 37(18):2689-91. PubMed ID: 23285909
[TBL] [Abstract][Full Text] [Related]
37. [Research progress of adverse reactions of traditional Chinese medicine injections].
Tan LJ; Wang M; Zhu Y
Zhongguo Zhong Yao Za Zhi; 2014 Oct; 39(20):3889-98. PubMed ID: 25751935
[TBL] [Abstract][Full Text] [Related]
38. [Thought on several problems of post-marketing herbs clinical evaluation in special populations].
Zhou A; Lian F
Zhongguo Zhong Yao Za Zhi; 2011 Oct; 36(20):2776-8. PubMed ID: 22292362
[TBL] [Abstract][Full Text] [Related]
39. [Analyze causes of adverse reactions induced by traditional Chinese medicine injections from its quality standards].
Cui HY; Liang AH
Zhongguo Zhong Yao Za Zhi; 2014 Mar; 39(5):934-40. PubMed ID: 25204194
[TBL] [Abstract][Full Text] [Related]
40. Postmarketing studies on safety of Dengfeng shenmai injection.
Wang L; Zhang W; Xie Y; Bai Y; Wang M; Ai Q
J Tradit Chin Med; 2013 Dec; 33(6):827-31. PubMed ID: 24660618
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
